Topical tazarotene cream (0.1%) in the treatment of facial acne: An open clinical trial

Authors

  • ASM Zakaria Department of Dermatology & Venereology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • HK Paul Department of Dermatology & Venereology, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • MA Rahman Department of Respiratory Medicine, Bangabandhu Sheikh Mujib Medical University, Dhaka
  • MT Islam Consultant Dermatology, Gowainghat Upazilla Health Complex, Sylhet
  • AM Choudhury Department of Dermatology & Venereology, Bangabandhu Sheikh Mujib Medical University, Dhaka

DOI:

https://doi.org/10.3329/bmrcb.v36i2.6985

Keywords:

tazarotene cream, facial acne

Abstract

Background: Tazarotene is a new 3rd generation topical acetylenic retinoid. It normalizes keratinocyte differentiation, reduces keratinocyte proliferation and decreases expression of inflammatory markers. Tazarotene was approved by US FDA in 1997 for acne vulgaris.

Objectives: To evaluate the efficacy and safety of topical tazarotene 0.1% cream in the treatment of facial acne.

Materials and methods: 67 patients with facial acne in the age range of 13-30 years were enrolled in the study. Purposive sampling was done. Patients were treated with topical Tazarotene cream (0.1%) and were instructed to apply the medication as a thin film over the affected area in the evening once daily for 12 weeks. Follow-up was done at 2nd, 4th week, 8th week and at 12th week.

Results: Of the 67 patients, 53% got remission, 9% had good response, 34% had poor response and there was no response in 4% of the patients by 12 weeks of treatment. Among the patients, 9 (13.43%) developed mild side effects.

Conclusion: Topical tazarotene cream (0.1%) is a effective and safe treatment option for acne vulgaris affecting face. It is mostly effective in grade-1 and grade-2 acne.

DOI: 10.3329/bmrcb.v36i2.6985

Bangladesh Med Res Counc Bull 2010; 36: 43-46

Downloads

Download data is not yet available.
Abstract
766
PDF
248

Downloads

How to Cite

Zakaria, A., Paul, H., Rahman, M., Islam, M., & Choudhury, A. (2011). Topical tazarotene cream (0.1%) in the treatment of facial acne: An open clinical trial. Bangladesh Medical Research Council Bulletin, 36(2), 43–46. https://doi.org/10.3329/bmrcb.v36i2.6985

Issue

Vol. 36 No. 2 (2010)

Section

Research Papers

License

Authors who publish with this journal agree to the following terms.

Authors retain copyright and grant the journal right of first publication.

Creative Commons Licence
Articles in the Bangladesh Medical Research Council Bulletin are licensed under a Creative Commons Attribution 4.0 International License (CC-BY) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).